Opinion on Drug Stores and Pharmacies in Europe

Published within

« | 1 | » »|

Type Product title / description Pub Price
Expert View
Expert View

Superdrug should emphasize quality when marketing new B range

Superdrug's premium skincare and makeup brand, B, is pitched as offering premium products with simplified purchasing and accessible prices. Effective communication of its products' impressive test results should boost sales, but B's affiliation to Superdrug, a retailer associated with value ranges, means that non-Superdrug shoppers who want a premium beauty experience will need some convincing.

Published By Datamonitor
16 Jan 2013
CommentWire
CommentWire

Schlecker: acquisition of smaller rival covers both ends of market

Schlecker is further strengthening its pole position in EU drug store retailing by buying its German competitor. By retaining the more upmarket Ihr Platz brand and focusing on a two-brand strategy, Schlecker is making the right move in Germany's tough and increasingly polarized retail environment.

Published By Datamonitor
04 Oct 2007
Expert View
Expert View

Pharmacy liberalization on hold: a sign of things to come?

While the EU's decision to halt the process of pharmacy liberalization is clearly based on the merit of one specific case (namely Doc Morris, the leading European online pharmacy), it could herald a sea change in terms of EU decision making. The move away from excessive deregulation towards a slower and more considered approach will bring both costs and benefits for EU consumers and patients.

Published By Datamonitor
19 Dec 2008
Expert View
Expert View

More brand awareness essential for Superdrug own label products

Over the past three years, Superdrug has been investing across its business to combat increasing competition from grocers and general merchandisers as well as the continuing threat from Boots. Despite this investment, with particular attention paid to its expanding own label range, the retailer still struggles to grow sales.

Published By Datamonitor
04 Dec 2012
CommentWire
CommentWire

MOL/Agip: forecourts to profit from poor health

Changes in legislation regarding the sale of over-the-counter medicines in Hungary have led two of the country's fuel retailers to announce plans to begin selling non-prescription drugs. With the Hungarian over-the-counter medicines market forecast to see an average annual increase of 5% between 2005 and 2009, Agip and MOL are certain to experience healthy profits from this venture.

Published By Datamonitor
07 Dec 2006
Expert View
Expert View

Lloydspharmacy: moving fast on acquisitions

Lloydspharmacy's parent Celesio announced it is buying 34 pharmacies from the Independent Pharmacy Care Centres chain which, when added to the 29 it recently bought from Manichem takes its community pharmacy chain to over 1,600. While Alliance Boots is preoccupied, Lloydspharmacy is cementing its position and undoubtedly more announcements will follow.

Published By Datamonitor
30 Apr 2007
CommentWire
CommentWire

Lloydspharmacy: expansion plans

Lloydspharmacy, the second largest community pharmacy chain in the UK behind Alliance Boots, has announced plans to more than double the number of pharmacies located in GP surgeries and health centers from 300 to 750. The move will help the company cement its position in local community healthcare.

Published By Datamonitor
01 Mar 2007
Expert View
Expert View

Boots: when less is more

Boots Group is expected to announce that it has reached agreement with the Office of Fair Trading regarding its merger with Alliance Unichem and the disposal of 104 stores. Although the divestments will hurt short-term revenue, they may benefit the company's bottom line in the long term by reducing store duplication in small communities.

Published By Datamonitor
13 Mar 2006
CommentWire
CommentWire

Boots-Alliance UniChem: rival challenge

The UK's Competition Appeal Tribunal will hear an objection to the Boots-Alliance UniChem merger from the German owner of Lloydspharmacy, Celesio. But even if the merger does not go ahead, Boots is now taking more interest in the sector, and its well-known brand name will make it a strong rival.

Published By Datamonitor
28 Mar 2006

« | 1 | » »|

No help is available.